drugset / Trial / NCT00224939

Pre-ESRD Syndrome in High Risk African Americans

NCT00224939 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment.

Timeline

Start
2002-07
Primary completion
—
Completion
2006-12

Outcome

Outcome not reported

Stopped (Enrollment): “Only apx 1/3 of enrolled subjects (signed consent) participated. Futility analysis to show primary endpoint”

Drugs

EvaluationDrugModalityDoseRoute
Subject Potassium Chloride Small molecule — —

Indications